Double Medical Technology Inc. (SHE:002901)
48.30
0.00 (0.00%)
At close: Dec 5, 2025
Double Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 19,639 | 12,579 | 16,805 | 14,062 | 20,310 | 29,536 | Upgrade
|
| Market Cap Growth | 37.45% | -25.15% | 19.50% | -30.76% | -31.23% | 24.82% | Upgrade
|
| Enterprise Value | 18,687 | 11,783 | 15,847 | 12,891 | 19,519 | 28,724 | Upgrade
|
| Last Close Price | 48.30 | 30.44 | 39.69 | 33.27 | 48.77 | 70.26 | Upgrade
|
| PE Ratio | 36.51 | 35.25 | 285.02 | 151.93 | 30.17 | 48.76 | Upgrade
|
| Forward PE | 38.95 | 60.69 | 60.69 | 60.69 | 60.69 | 60.69 | Upgrade
|
| PS Ratio | 7.91 | 5.89 | 10.96 | 9.81 | 10.18 | 18.61 | Upgrade
|
| PB Ratio | 5.71 | 3.95 | 5.32 | 4.53 | 7.85 | 13.84 | Upgrade
|
| P/TBV Ratio | 6.23 | 4.36 | 5.89 | 5.05 | 8.85 | 15.03 | Upgrade
|
| P/FCF Ratio | 35.17 | 73.20 | - | - | 46.36 | 70.55 | Upgrade
|
| P/OCF Ratio | 27.98 | 28.44 | 227.43 | 109.48 | 30.17 | 53.14 | Upgrade
|
| EV/Sales Ratio | 7.53 | 5.52 | 10.34 | 8.99 | 9.79 | 18.10 | Upgrade
|
| EV/EBITDA Ratio | 28.14 | 26.37 | 130.66 | 110.07 | 24.96 | 42.03 | Upgrade
|
| EV/EBIT Ratio | 35.04 | 35.24 | 813.83 | 417.18 | 27.21 | 45.37 | Upgrade
|
| EV/FCF Ratio | 33.47 | 68.57 | - | - | 44.55 | 68.61 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.12 | 0.19 | 0.02 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.44 | 0.84 | 4.57 | 0.55 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | 0.53 | 2.24 | - | - | 0.05 | - | Upgrade
|
| Asset Turnover | 0.55 | 0.47 | 0.36 | 0.39 | 0.66 | 0.65 | Upgrade
|
| Inventory Turnover | 0.60 | 0.58 | 0.50 | 0.42 | 0.53 | 0.46 | Upgrade
|
| Quick Ratio | 2.11 | 1.59 | 1.66 | 2.35 | 2.34 | 3.19 | Upgrade
|
| Current Ratio | 3.77 | 2.99 | 2.74 | 3.80 | 3.32 | 4.47 | Upgrade
|
| Return on Equity (ROE) | 17.05% | 12.15% | 2.76% | 3.85% | 29.29% | 31.63% | Upgrade
|
| Return on Assets (ROA) | 7.40% | 4.61% | 0.28% | 0.53% | 14.90% | 16.23% | Upgrade
|
| Return on Capital (ROIC) | 9.06% | 5.70% | 0.35% | 0.67% | 18.91% | 20.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.20% | 9.60% | 0.60% | 1.00% | 27.00% | 28.80% | Upgrade
|
| Earnings Yield | 2.76% | 2.84% | 0.35% | 0.66% | 3.31% | 2.05% | Upgrade
|
| FCF Yield | 2.84% | 1.37% | -1.38% | -1.11% | 2.16% | 1.42% | Upgrade
|
| Dividend Yield | 1.04% | 1.64% | 0.63% | - | 1.03% | 1.14% | Upgrade
|
| Payout Ratio | 39.67% | 33.09% | 16.00% | 226.22% | 48.14% | 39.85% | Upgrade
|
| Buyback Yield / Dilution | 2.80% | 1.49% | -0.10% | -4.35% | -0.52% | 0.04% | Upgrade
|
| Total Shareholder Return | 3.83% | 3.13% | 0.53% | -4.35% | 0.51% | 1.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.